Lockheed Martin: The Proposed 2027 Defense Budget Makes The Bull Case Hard To Ignore

Lockheed Martin (LMT) is ~24% below its 52-week high despite $186.4B in backlog and robust demand signals. The proposed $1.5T U.S. defense budget for 2027, including a 28% base increase, is framed as strongly supportive of LMT’s core programs and munitions ramp. Contract structures include 7-year, inflation-indexed munitions deals, alongside a path to Dividend Aristocrat status with a 2.57% dividend yield and 23 consecutive years of increases.

Analysis

This is a backlog-to-cash-flow story more than a headline-budget story. The marginal upside for LMT comes from mix: inflation-indexed, multi-year munitions work should translate into cleaner margin capture and lower execution risk than the usual fixed-price development programs, while also pulling through demand to energetics, electronics, and machining suppliers that have been underinvested for years. That creates a second-order winner set in the defense industrial complex, especially for capacity-constrained subcontractors that can reprice faster than the primes.

The market may still be underpricing the lag between authorization and appropriation. Defense multiples rarely rerate on proposal language alone; they rerate when backlog converts into shipment growth and free cash flow proves durable over 2-4 quarters. The key falsifier is any sign that revenue growth is being “bought” with margin dilution, or that Congress trims the eventual spending package enough to slow munitions cadence below current assumptions.

Contrarian view: the stock’s discount to recent highs may already reflect skepticism that budget headlines become realized cash flow, which is exactly why the setup can work if execution stays clean. LMT is less levered to GDP than most industrials, so in a risk-off tape it can act as a defensive compounder, but it can still lag if rates fall sharply and investors rotate toward longer-duration growth. The real catalyst path is 1-3 months of contract awards and budget markups, with 6-18 months of production-throughput evidence driving multiple expansion.

Key Decisions for Investors

• Build a tactical long in LMT on any weakness over the next 2-6 weeks; base case is a 6-12 month rerating as backlog converts into higher FCF, with downside limited unless appropriations materially underdeliver.
• Relative-value idea: long LMT / short NOC for the next 1-2 quarters if the market starts rewarding production certainty over development-heavy exposure; thesis fails if NOC shows faster program execution or better margin conversion.
• If you want cleaner beta-neutral exposure, long LMT vs short XLI as a 3-6 month pair; this isolates defense-specific budget upside and reduces macro industrial noise.
• Set an alert for the first appropriations mark-up and next earnings guide: if management does not raise confidence on margin conversion or free cash flow, treat the move as headline-driven and reduce exposure.